ANXA1 expression in tumors was found to be tissue-specific, as evidenced by increased levels in lung, liver, and colorectal cancers, while it showed decreased levels in prostate, nasopharyngeal, and oral squamous cell carcinomas [29–34]. This evidence concerns the gene ANXA1 and colorectal cancer.